Company / PP&E (Net)
Elanco PP&E (Net) History
FY2017-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
$993.0M
FY2024
5-year range
$993.0M / $1.1B
FY2020-FY2024
Trend
-3.2%
vs FY2023
Sector context
#17 of 193
Health Care
What the data says
Among 193 Health Care companies, Elanco is in the top 9% for pp&e (net). PP&E (Net) has fluctuated over the past 8 years, ranging from $920M in FY2017 to $1.3B in FY2020.
Based on SEC 10-K filings.
$993M in FY2024 with a 5-year CAGR of +0.8%. Top quartile in the Health Care sector.
Remained stable around $993M over the past 2 years.
Health Care sector context is included.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- -2.0%
- 5-Year CAGR
- +0.8%
- 10-Year CAGR
- -
Sector benchmark
Top 9% in Health CareTop 9% of 193This company $993.0M Sector average $777.6M
▼
+27.7% above sector average
Key checks
Key Insights
- 5-year CAGR of +0.8%, indicating consistent growth.
- In FY2024, pp&e (net) decreased 3.2% year-over-year.
- Ranks #17 out of 193 companies in the Health Care sector.
- Peak pp&e (net) was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score 0.72 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | $993.0M | -3.2% |
| FY2023 | $1.0B | +2.7% |
| FY2022 | $999.0M | -5.3% |
| FY2021 | $1.1B | -19.8% |
| FY2020 | $1.3B | +37.8% |
| FY2019 | $955.3M | +3.6% |
| FY2018 | $922.4M | +0.2% |
| FY2017 | $920.3M | - |
| FY2016 | - | - |
As of FY2024 · SEC 10-K · Updated Jul 2, 2026